Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-01

Clinical Trial Update: Creon in HIV Patients With Steatorrhea [Phase 3]

View source ↗

Summary

A Phase 3 trial of Creon (pancrelipase) in HIV patients with steatorrhea has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Creon (pancrelipase)

Snippet

Sponsor: Abbott | Conditions: Steatorrhea | Phase 3 | Status: TERMINATED